TRAVERSA SERGIO 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 19, 2023
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-15+183,881→ 183,881 totalExercise: $2.48From: 2024-03-15Exp: 2033-12-15→ Common Stock (183,881 underlying)
Footnotes (1)
- [F1]The options vest in 16 equal quarterly installments commencing on March 15, 2024.